TRICORTIN
ItalyIt is prescribed for the treatment of polyalgic-neuropsychic syndromes.
Frequently asked questions
How should TRICORTIN 1000 be taken?
It is taken by injecting one ampoule per day intramuscularly, following the doctor's instructions.
When should you not use this medicine?
It must not be used in case of hypersensitivity to the components of the product or to other substances closely related from a chemical point of view.
Can TRICORTIN 1000 cause side effects?
At this time, no adverse effects related to the drug have been reported.
Are there interactions with other medicines?
No interactions between this drug and other medicines have been identified.
Can it be used during pregnancy or breastfeeding?
The drug may be administered during pregnancy and breastfeeding, but only under the direct supervision of a doctor.
Does the drug affect driving or the use of machinery?
The drug does not interfere with the ability to drive or use machines.
Instructions for use
Table of contents
Package leaflet
TRICORTIN 1000 12 mg+1mg/2 ml injectable solution for intramuscular use
Cerebral cortex phospholipids + cyanocobalamin
COMPOSITION
Active substances:
Cerebral cortex phospholipids 12 mg
Cyanocobalamin 1000 mcg
Excipients:
Hydrochloride lidocaine - disodium phosphate 12H O - monosodium phosphate 2H O - esters of p-hydroxybenzoic
acid - water for injections q.s. to 2 ml
PHARMACEUTICAL FORM
Injectable solution for intramuscular use.
5 vials of 2 ml
THERAPEUTIC PHARMACOLOGICAL CATEGORY
Psycholeptics - other psychostimulants and nootropics - combinations.
MARKETING AUTHORISATION HOLDER AND MANUFACTURER
Fidia Farmaceutici S.p.A. - Via Ponte della Fabbrica, 3/A - 35031 Abano Terme (PD)
THERAPEUTIC INDICATIONS
Polyalgic-neurotic syndromes
CONTRAINDICATIONS
Hypersensitivity to the components of the product and to other substances closely related from a chemical
standpoint.
PRECAUTIONS FOR USE
The drug does not require special precautions for use.
INTERACTIONS
No interactions between TRICORTIN 1000 and other drugs have been reported.
WARNINGS
The drug may be administered during pregnancy and lactation under direct medical supervision. The drug does not interfere with the ability to drive or operate machinery.
DOSAGE, METHOD AND TIMES OF ADMINISTRATION
1 vial per day by intramuscular route, as prescribed by a physician.
OVERDOSAGE
No symptoms of overdose have ever been observed at the recommended doses.
UNDESIRABLE EFFECTS
To date, no adverse effects related to the drug have been reported. However, inform your physician or pharmacist about any adverse effects not described in this leaflet.
The expiry date stated on the packaging refers to the product in its original, unopened packaging, correctly stored.
Store below 25 °C.
Caution: do not use the medicine after the expiry date stated on the packaging
The original data is available in the language of the country of manufacture.
Data source: Italian Medicines Agency (AIFA)
Data last verified: September 21, 2026